Adamax

⏱ Half-Life

Short–Moderate duration profile

Adamax demonstrates a short–moderate half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.

⚡ Onset Characteristics

Fast measurable response

Onset is observed as fast — a property that influences how researchers structure comparative studies versus other compounds in the cognitive research category.

🧠 Key Notes

What makes it distinct

• 01Structural analog within the ACTH(4-10) / Semax family
• 02Studied for extended BDNF and NGF upregulation
• 03Intranasal administration common in research literature

🧬 Mechanism of Action

How it works

Adamax is a modified analog of the ACTH(4-10) fragment family that includes Semax and Selank. Its extended N-terminal modification increases enzymatic stability compared with Semax, allowing prolonged interaction with melanocortin and BDNF/NGF signalling pathways. This produces sustained upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the hippocampus and cortex, supporting synaptic plasticity, memory consolidation, and stress-response modulation. Intranasal delivery bypasses the blood-brain barrier via olfactory transport, achieving CNS bioavailability without systemic exposure.

✨ Documented Benefits

What the research shows it supports

🔍 Research Insights

What the literature shows

🧪 Typical Research Use Cases

Where it appears in study design

📚 References

Peer-reviewed literature

Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.

1. [01]

   Kaplan, A. Ya. et al. (1996). Synthetic ACTH analogue Semax displays nootropic-like activity in humans. Neuroscience Research Communications, 19(2), 115–123.

   Neuroscience Research Communications ↗
2. [02]

   Dolotov, O. V. et al. (2006). Semax, an analog of ACTH(4-10), regulates expression of BDNF and trkB in the rat hippocampus. Neurochemical Journal, 27(2), 160–166.

   Journal of Neurochemistry ↗
3. [03]

   Ashmarin, I. P. et al. (2005). Nootropic activity of proline-containing peptides: analogs of ACTH(4-10). Neuroscience and Behavioral Physiology, 35(6), 555–560.

   Neuroscience and Behavioral Physiology ↗
4. [04]

   Levitskaya, N. G. et al. (2008). The melanocortin system. Neuroscience and Behavioral Physiology, 38(4), 407–420.

   Neuroscience and Behavioral Physiology ↗